Patients with chronic renal failure under hemodialysis. Chronic kidney disease, stage 5
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Ability to communicate and answer questions Consent to participate in the study and sign the informed consent form Healthy sense of smell Not having an anxiety disorders Not having a history of using aromatherapy Not having asthma and allergies Not brushing teeth At least three months have passed since hemodialysis Doing dialysis at least 2 to 3 times a week Not taking corticosteroids and immunosuppressants Not having active infection Not having a history of organ transplant rejection Dialysis in the morning shift No history of cancer
Exclusion criteria
Exclusion criteria: Allergy to Rosa damascene and patient reaction to it Taking anti-anxiety and anti-depressant drugs Performing a kidney transplant during the study Change of dialysis method from hemodialysis to peritoneal dialysis during the intervention Hospitalization in the intensive care unit during the intervention
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Salivary cortisol levels. Timepoint: Salivary cortisol levels at the beginning of the study (before the intervention) and one month later. Method of measurement: By ELISA kits.;Quality of life. Timepoint: Quality of life at the beginning of the study (before the intervention) and one month later. Method of measurement: Kidney Disease Quality of Life-Short Form (KDQOL-SF) questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Yasouj University of Medical Sciences